Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice

Authors

Dongju Park
Mehdi Gharghabi
Colleen R Reczek
Rebecca Plow
Charles Yungvirt
C Marcelo Aldaz
Kay Huebner

Publication Date

3-28-2022

Journal

International Journal of Molecular Sciences

Abstract

Wwox-deficient human cells show elevated homologous recombination, leading to resistance to killing by double-strand break-inducing agents. Human Wwox binds to the Brca1 981-PPLF-984 Wwox-binding motif, likely blocking the pChk2 phosphorylation site at Brca1-S988. This phosphorylation site is conserved across mammalian species; the PPLF motif is conserved in primates but not in rodents. We now show that murine Wwox does not bind Brca1 near the conserved mouse Brca1 phospho-S971 site, leaving it open for Chk2 phosphorylation and Brca1 activation. Instead, murine Wwox binds to Brca1 through its BRCT domain, where pAbraxas, pBrip1, and pCtIP, of the A, B, and C binding complexes, interact to regulate double-strand break repair pathway response. In Wwox-deficient mouse cells, the Brca1-BRCT domain is thus accessible for immediate binding of these phospho-proteins. We confirm elevated homologous recombination in Wwox-silenced murine cells, as in human cells. Wwox-deficient murine cells showed increased ionizing radiation-induced Abraxas, Brca1, and CtIP foci and long resected single-strand DNA, early after ionizing radiation. Wwox deletion increased the basal level of Brca1-CtIP interaction and the expression level of the MRN-CtIP protein complex, key players in end-resection, and facilitated Brca1 release from foci. Inhibition of phospho-Chk2 phosphorylation of Brca1-S971 delays the end-resection; the delay of premature end-resection by combining Chk2 inhibition with ionizing radiation or carboplatin treatment restored ionizing radiation and platinum sensitivity in Wwox-deficient murine cells, as in human cells, supporting the use of murine in vitro and in vivo models in preclinical cancer treatment research.

Keywords

Animals, BRCA1 Protein, Carrier Proteins, Cell Cycle Proteins, DNA, DNA Breaks, Double-Stranded, DNA Helicases, DNA Repair, Endodeoxyribonucleases, Homologous Recombination, Mammals, Mice, WW Domain-Containing Oxidoreductase, end-resection at DSBs, Wwox deficiency, Chk2 inhibition, IR and platinum treatment resistance

DOI

10.3390/ijms23073729

PMID

35409089

PMCID

PMC8999063

PubMedCentral® Posted Date

3-28-2022

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes